超大色素上皮质脱落对静脉内勃鲁西祖马布注射的反应
Somnath Chakraborty1, Jay Umed Sheth2
1Department of Vitreoretinal Services, Retina Institute of Bengal, Siliguri, India.
American journal of ophthalmology case reports
|May 30, 2023
概括
静脉内勃鲁西祖马布有效地治疗由黄斑新血管化 (MNV) 引起的超大色素上皮质脱落 (PED). 这种治疗显示PED显著降低身高和视觉改善,在一个小的病例系列中没有安全问题.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 黄斑新血管化 (MNV) 可能导致色素上皮质脱落 (PED),这种情况可能会损害视力.
- 超大PED (>350微米) 具有重大临床挑战,特别是在以前未接受治疗的患者中.
研究的目的:
- 评估布罗卢齐祖马布静脉内注射 (IVI) 的疗效和安全性,用于治疗MNV继发的超大PED.
主要方法:
- 一个前性的,非随机的,不受控制的病例系列,涉及三名未经治疗的MNV相关的超大PED患者.
- 患者接受了静脉内勃鲁西祖马布,结果评估了PED身高,视力敏度和安全性.
主要成果:
- 到第4周,PED高度显著改善,到第8周,三只眼睛中的两只眼睛完全消失.
- 所有接受治疗的眼睛都经历了显著的视觉改善.
- 在研究期间,没有报告眼部或全身安全问题.
结论:
- 静脉内勃鲁西祖马布证明了在未经治疗的MNV眼睛中管理超大PED的有效性和有利的安全性.
- 进一步研究布罗卢齐祖马布的药理疗作用是有必要的,以阐明其在亚RPE和胆道水平的作用机制.
相关概念视频
Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...


